Often, therapeutic development has focused on tiny agents, but peptide alliances are progressively receiving attention. This innovative strategy embraces combining peptides with complementary therapeutic modalities to tackle complex condition mechanisms. By leveraging the distinctive features of amino acid sequences – such as high specificity and